Product profiles: Top stories on the new product innovations in the APAC beauty space In our round-up of the recent product developments in the Asia Pacific beauty and personal care market, we highlight the latest innovations from Swisse, Kosé, Antipodes and more.
1 – In and out beauty: Swisse extends revamped beauty range to complement supplement business
Swisse is ramping up new product development for its revamped beauty range as part of its focus into the ‘beauty in and out’ market in Australia and worldwide.
Owned by the Health & Happiness Group (H&H), the wellness and vitamin brand relaunched its skin care business in April 2020, to complement its supplement business.
In and out beauty: Swisse extends revamped beauty range to complement supplement business Swisse is ramping up new product development for its revamped beauty range as part of its focus into the ‘beauty in and out’ market in Australia and worldwide.
Owned by the Health & Happiness Group (H&H), the wellness and vitamin brand relaunched its skin care business in April 2020, to complement its supplement business.
“
Although we have had a skin care range for several years, we are increasingly making it a core focus of the business. We have heavily invested time, effort, and innovation in skin care as it is organically symbiotic to our vitamin and supplement products,” said Nick Mann, managing director at Swisse Wellness.
Bod Australia (ASX:BDA) begins expansion efforts with first U S order themarketherald.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketherald.com.au Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
SAN FRANCISCO, Jan. 7, 2021 /PRNewswire/ Nalu Bio, Inc. today announced the successful organic synthesis of CBD (cannabidiol) utilizing its proprietary technology platform, closure of its seed financing, and the successful recruitment of a world-class team of life science and consumer packaged goods professionals to develop and scale the company s innovative technology. Nalu Bio s vision for the organic synthesis and cost-effective mass production of CBD mimics the history of aspirin - the therapeutic value of aspirin for pain relief was uncovered, is now mass-produced in the lab, and has become the most commonly used drug in the world.